Macquarie Group LTD Lannett CO Inc Transaction History

Macquarie Group LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$5.75 - $7.13 $18,578 - $23,037	-3,231 Reduced 6.81%	44,200 $288,000
Q2 2020 Aug 11, 2020	BUY	$6.43 - $9.86 $20,775 - $31,857	3,231 Added 7.31%	47,431 $344,000
Q1 2019 May 15, 2019	SELL	$5.35 - $9.82 $49,220 - $90,344	-9,200 Reduced 17.23%	44,200 $348,000
Q4 2018 Feb 15, 2019	BUY	$3.43 - $6.19 $2,401 - $4,333	700 Added 1.33%	53,400 $265,000
Q3 2018 Nov 15, 2018	SELL	$4.75 - $14.5 $88,350 - $269,700	-18,600 Reduced 26.09%	52,700 $250,000
Q2 2018 Aug 14, 2018	SELL	$13.3 - $17.45 $15,960 - $20,940	-1,200 Reduced 1.66%	71,300 $970,000
Q1 2018 May 11, 2018	BUY	$14.7 - $24.95 $179,340 - $304,390	12,200 Added 20.23%	72,500 $1.16 Million
Q4 2017 Feb 15, 2018	BUY	$19.9 - $29.25 $238,799 - $351,000	12,000 Added 24.84%	60,300 $1.4 Million
Q3 2017 Nov 08, 2017	BUY	$15.1 - $19.25 $729,330 - $929,775	48,300	48,300 $891,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.